Dec 21, 2025 04:00AM
Aug 6, 2025 04:01PM
May 7, 2025 04:01PM
May 9, 2024 04:09PM
May 5, 2022 04:01PM
Feb 24, 2022 06:00AM
Feb 23, 2022 04:01PM Xencor Reports Fourth Quarter and Full Year 2021 Financial Results
Aug 4, 2021 04:01PM
May 26, 2021 07:46PM
May 5, 2021 04:01PM
Feb 25, 2021 05:01AM
Feb 23, 2021 04:01PM
Dec 29, 2020 07:42AM
Nov 11, 2020 04:04PM Xencor (XNCR), MorphoSys (MOR) and Incyte (INCY) Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab
Nov 11, 2020 04:02PM
Nov 5, 2020 04:01PM
Aug 4, 2020 04:01PM
Jul 31, 2020 10:49PM
May 7, 2020 04:01PM
Feb 24, 2020 04:01PM
Feb 5, 2020 08:08AM Aimmune Therapeutics (AIMT) Reports Licensing of Exclusive Worldwide Rights to Xencor (XNCR) XmAb7195 for Development of Next-Generation Food Allergy Treatments
Dec 18, 2019 08:01AM
Nov 5, 2019 04:01PM
May 9, 2019 04:00PM
Apr 30, 2019 08:12AM
Apr 30, 2019 08:01AM
Feb 25, 2019 04:24PM
Feb 20, 2019 07:09AM Xencor (XNCR) Announces Partial Clinical Hold on Phase 1 Study of XmAb14045
Feb 20, 2019 06:55AM
Nov 8, 2018 09:05AM
Nov 8, 2018 09:01AM
Nov 5, 2018 04:01PM
May 7, 2018 04:01PM
Mar 21, 2018 09:13AM
Feb 27, 2018 04:01PM Xencor Reports Fourth Quarter and Full Year 2017 Financial Results
Jan 5, 2018 08:10AM
Jan 5, 2018 08:00AM
Nov 7, 2017 04:01PM
Aug 7, 2017 04:01PM
May 11, 2017 08:09AM
May 11, 2017 08:00AM
Apr 17, 2017 08:03AM Xencor (XNCR) Appoints Kevin Gorman to Board of Directors
Apr 17, 2017 08:00AM
Feb 28, 2017 04:06PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All